Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis

29 May 2019

Abstract excerpt

Background: Monoamine oxidases (MAOs) were discovered nearly a century ago. This article aims to analyze the research literature landscape associated with MAOs as privileged class of neuronal enzymes (neuroenzymes) with key functions in the processes of neurodegeneration, serving as important biological targets in neuroscience. With the accumulating publications on this topic, we aimed to evaluate the publication...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attention Deficit Hyperactivity Disorder
Share to Biotin and Related Studies

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 31191248
DOI: 10.3389/fnmol.2019.00143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature AnalysisPMID 31191248Read ↗

Monoamine Oxidase Inhibitors in Drug Discovery Against Parkinson’s Disease: A Brief ReviewSemantic proximity Read ↗

Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapySemantic proximity Read ↗

Type A monoamine oxidase; its unique role in mood, behavior and neurodegenerationSemantic proximity Read ↗

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson’s diseaseSemantic proximity Read ↗

Monoamine oxidase: radiotracer chemistry and human studies.Semantic proximity Read ↗

Brunner syndrome associated MAOA dysfunction in human dopaminergic neurons results in NMDAR hyperfunction and increased network activitySemantic proximity Read ↗

Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.Semantic proximity Read ↗

Monoamine oxidase in neuropsychiatry and behavior.Semantic proximity Read ↗

Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs.Semantic proximity Read ↗

Relationship between COVID-19 infection and neurodegeneration: Computational insight into interactions between the SARS-CoV-2 spike protein and the monoamine oxidase enzymesSemantic proximity Read ↗

Exploring the Pharmacological & Therapeutic Potential of Monoamine Oxidase Inhibitors in Lung Cancer Treatment: Unearthing Novel Pathways for Clinical AdvancementSemantic proximity Read ↗

MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.